Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Loss of function of ENT3 drives histiocytosis and inflammation through TLR-MAPK signaling

Blood (2023) 142 (20): 1740–1751.

https://doi.org/10.1182/blood.2023020714

Published: 2023

Includes: Supplemental data

Journal Articles

ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells

Blood (2022) 139 (3): 399–412.

https://doi.org/10.1182/blood.2020010405

Published: 2022

Includes: Supplemental data

Journal Articles

Stearoyl-CoA Desaturase (SCD) Enhances Central Nervous System Leukemia

Angela Maria Savino, PhD, Orianne Olivares, PhD, Shani Barel, Lev Yakimov, Ifat Geron, Hila Fishman, Inbal Mor, Ifat Abramovich, Sara Isabel Fernandes, Eyal Gottlieb, Christina Halsey, MD PhD, Shai Izraeli, MD

Blood (2018) 132 (Supplement 1): 389.

https://doi.org/10.1182/blood-2018-99-114749

Published: 2018

Journal Articles

Activation of CRLF2/IL7RA Signaling in Normal Human Cord Blood Hematopoietic Progenitors Induces Philadelphia-like B-Cell Precursor Pre-Leukemia and Leukemia In Vivo

Ifat Geron, PhD, Angela Maria Savino, PhD, Noa Tal, MD PhD, John Brown, PhD, Virginia A Turati, DPhil, Yu Nee Lee, PhD, Chela James, PhD, Avigail Rein Gil, MD, Yehudit Birger, PhD, Inna Muler, Michal Hameiri, PhD, Victoria Marcu-Malina, PhD, Ute Fischer, PhD, Arndt Borkhardt, MD, Ilan M. Kirsch, MD, Arnon Nagler, MD, Tariq Enver, PhD, Shai Izraeli, MD

Blood (2018) 132 (Supplement 1): 566.

https://doi.org/10.1182/blood-2018-99-115913

Published: 2018

Journal Articles

MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome

Lital Shaham, Elena Vendramini, Yubin Ge, Yaron Goren, Yehudit Birger, Marloes R. Tijssen, Maureen McNulty, Ifat Geron, Omer Schwartzman, Liat Goldberg, Stella T. Chou, Holly Pitman, Mitchell J. Weiss, Shulamit Michaeli, Benjamin Sredni, Berthold Göttgens, John D. Crispino, Jeffrey W. Taub, Shai Izraeli

Blood (2015) 125 (8): 1292–1301.

https://doi.org/10.1182/blood-2014-06-581892

Published: 2015

Includes: Supplemental data

Journal Articles

Inhibition Of Inflammation Driven Leukemia Stem Cell Self-Renewal With a Selective JAK2 Antagonist

Angela C Court Recart, BS, MS, Anil Sadarangani, PhD, Elizabeth Chun, MSc, Cayla N Mason, BS, Qingfei Jiang, PhD, Christian L Barrett, Ph.D., Russell Wall, BS, Daniel J Goff, PhD, Ifat Geron, MSc, Alice Shih, Heather S. Leu, B.S., Wenxue Ma, M.D., Ph.D., Mark D. Minden, MD PhD, Kelly A Frazer, Ph.D., Marco A. Marra, PhD, Leslie A Crews, PhD, Catriona HM Jamieson, MD, PhD

Blood (2013) 122 (21): 1481.

https://doi.org/10.1182/blood.V122.21.1481.1481

Published: 2013

Journal Articles

BCL2 Splice Isoform Switching Promotes Leukemia Stem Cell Survival and Sensitivity to a Novel Pan BCL2 Inhibitor

Blood (2011) 118 (21): 2735.

https://doi.org/10.1182/blood.V118.21.2735.2735

Published: 2011

Journal Articles

Cycling Toward Leukemia Stem Cell Elimination Wtih a Selective Sonic Hedgehog Antagonist,

Blood (2011) 118 (21): 3776.

https://doi.org/10.1182/blood.V118.21.3776.3776

Published: 2011

Journal Articles

Human Blast Crisis Leukemia Stem Cell Inhibition with a Novel Smoothened Antagonist.

Annelie Schairer, Ph.D., Alice Shih, BS, Ifat Geron, MSc, Tannishtha Reya, PhD, Wendy J. Levin, MD, MS, Todd Van Arsdale, PhD, Catriona Jamieson, MD, PhD

Blood (2010) 116 (21): 1223.

https://doi.org/10.1182/blood.V116.21.1223.1223

Published: 2010

Journal Articles

Deregulated Bcl-2 Family Expression Drives Chronic Myeloid Leukemia Cancer Stem Cell Survival.

Daniel Jacob Goff, Annelie Abrahamsson, Ifat Geron, Catriona Jamieson, MD, PhD

Blood (2008) 112 (11): 1074.

https://doi.org/10.1182/blood.V112.11.1074.1074

Published: 2008

Journal Articles

Selective Inhibition of JAK2 Driven Erythroid Differentiation of Polycythemia Vera Progenitors

Ifat Geron, MS, Annelie Abrahamsson, MS, Charlene Barroga, PhD, Edward Kavelerchik, MD, Jason R. Gotlib, MD MS, John D. Hood, PhD, Jeffrey Durocher, PhD, Chi Ching Mak, PhD, Glen Noronha, PhD, Richard Soll, PhD, Ayalew Tefferi, MD, Kenneth Kaushansky, MD, Catriona H.M. Jamieson, MD PhD

Blood (2007) 110 (11): 1526.

https://doi.org/10.1182/blood.V110.11.1526.1526

Published: 2007

Journal Articles

Missplicing of Glycogen Synthase Kinase 3β: A Potential Mechanism of Blast Crisis Chronic Myeloid Leukemia Stem Cell Generation.

Annelie Abrahamsson, MS, Ifat Geron, MS, Jason Gotlib, MD MS, Kim-Hien Dao, DO PhD, Francis Giles, MD, Isabel Newton, MD PhD, Edward Kavalerchik, MD, Jeffrey Durocher, PhD, Remi Creusot, PhD, Mobin Karimi, PhD, Carol Jones, PhD, James Zehnder, PhD, Armand Keating, MD, Robert Negrin, MD, Irving L. Weissman, MD, Catriona H.M. Jamieson, MD PhD

Blood (2007) 110 (11): 775.

https://doi.org/10.1182/blood.V110.11.775.775

Published: 2007

Journal Articles

Inhibition of Chronic Myelogenous Leukemia Stem Cells with Novel Wnt Antagonists.

Edward Kavalerchik, MD, Jason Gotlib, MD MS, Ifat Geron, MS, Annelie Abrahamsson, MS, Wolfgang Wrasidlo, PhD, Daniel Goff, BS, Desheng Lu, PhD, Ted Molinski, PhD, Francis Giles, MD, Irving Weissman, MD, Dennis Carson, MD, Catriona Jamieson, MD PhD

Blood (2006) 108 (11): 238.

https://doi.org/10.1182/blood.V108.11.238.238

Published: 2006

Journal Articles

Inhibition of JAK2 V617F-Induced Erythroid Skewing of Hematopoietic Stem Cell Differentiation with a Selective JAK2 Antagonist.

Ifat Geron, MS, Charlene Barroga, PhD, Jason Gotlib, MD MS, Edward Kavalerchik, MD, Annelie Abrahamsson, MS, Daniel Goff, BS, Nicholas Cacalano, PhD, John Hood, PhD, Richard Soll, MD, Glenn Noronha, PhD, Ayalew Tefferi, MD, Irving L. Weissman, MD, Kenneth Kaushansky, MD PhD, Catriona Jamieson, MD, PhD

Blood (2006) 108 (11): 3616.

https://doi.org/10.1182/blood.V108.11.3616.3616

Published: 2006

Journal Articles

Aberrant Regulation of Wnt/Beta-Catenin Pathway Mediators in Chronic Myelogenous Leukemia Stem Cells.

Annelie Abrahamsson, MS, Ifat Geron, MS, Jason Gotlib, MD MS, Jeffrey Durocher, PhD, Remi Creusot, PhD, Edward Kavalerchik, MD, Daniel Goff, BS, C.G. Fathman, MD, Stanley L. Lilleberg, PhD, Francis Giles, MD, Irving Weissman, MD, Catriona Jamieson, MD, PhD

Blood (2006) 108 (11): 2135.

https://doi.org/10.1182/blood.V108.11.2135.2135

Published: 2006

NARROW

Loss of function of ENT3 drives histiocytosis and inflammation through TLR-MAPK signaling

ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells

Stearoyl-CoA Desaturase (SCD) Enhances Central Nervous System Leukemia

Activation of CRLF2/IL7RA Signaling in Normal Human Cord Blood Hematopoietic Progenitors Induces Philadelphia-like B-Cell Precursor Pre-Leukemia and Leukemia In Vivo

MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome

Inhibition Of Inflammation Driven Leukemia Stem Cell Self-Renewal With a Selective JAK2 Antagonist

BCL2 Splice Isoform Switching Promotes Leukemia Stem Cell Survival and Sensitivity to a Novel Pan BCL2 Inhibitor

Cycling Toward Leukemia Stem Cell Elimination Wtih a Selective Sonic Hedgehog Antagonist,

Human Blast Crisis Leukemia Stem Cell Inhibition with a Novel Smoothened Antagonist.

Deregulated Bcl-2 Family Expression Drives Chronic Myeloid Leukemia Cancer Stem Cell Survival.

Selective Inhibition of JAK2 Driven Erythroid Differentiation of Polycythemia Vera Progenitors

Missplicing of Glycogen Synthase Kinase 3β: A Potential Mechanism of Blast Crisis Chronic Myeloid Leukemia Stem Cell Generation.

Inhibition of Chronic Myelogenous Leukemia Stem Cells with Novel Wnt Antagonists.

Inhibition of JAK2 V617F-Induced Erythroid Skewing of Hematopoietic Stem Cell Differentiation with a Selective JAK2 Antagonist.

Aberrant Regulation of Wnt/Beta-Catenin Pathway Mediators in Chronic Myelogenous Leukemia Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only